Search research articles
Contact Us
Filters
Showing results (51-60 of 146) with videos related to
Page
of 15
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
Bachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Blood
|
September 25, 2024
Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
Holly Lee, Michael Durante, Sheri Skerget, et al.
Blood Cancer Journal
|
May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Cody Ashby, Eileen M Boyle, Michael A Bauer, et al.
Nature Communications
|
August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Leo Rasche, Carolina Schinke, Francesco Maura, et al.
Leukemia & Lymphoma
|
April 16, 2014
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide
Vittorio Montefusco, Monica Galli, Francesco Spina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2020
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
Mattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Blood Advances
|
November 4, 2022
Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations
Kylee H Maclachlan, Tina Bagratuni, Efstathios Kastritis, et al.
Blood
|
April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
Michael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
NPJ Precision Oncology
|
October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 146) with videos related to
Sort By:
Page
of 15
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
Bachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Blood
|
September 25, 2024
Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
Holly Lee, Michael Durante, Sheri Skerget, et al.
Blood Cancer Journal
|
May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Cody Ashby, Eileen M Boyle, Michael A Bauer, et al.
Nature Communications
|
August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Leo Rasche, Carolina Schinke, Francesco Maura, et al.
Leukemia & Lymphoma
|
April 16, 2014
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide
Vittorio Montefusco, Monica Galli, Francesco Spina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2020
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
Mattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Blood Advances
|
November 4, 2022
Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations
Kylee H Maclachlan, Tina Bagratuni, Efstathios Kastritis, et al.
Blood
|
April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
Michael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
NPJ Precision Oncology
|
October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
Page
of 15